US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist

368.430
-4.380-1.17%

Close Oct 18 16:00 ET

366.000
-2.430-0.66%

Post 20:02 ET

16.39BMarket Cap16.93P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

118.44%232.2M

0.45%376.5M

21.87%978M

17.55%150.7M

33.87%346.2M

-16.30%106.3M

29.82%374.8M

34.15%802.5M

-26.58%128.2M

39.33%258.6M

Net income from continuing operations

7.29%278.1M

27.27%306.6M

35.40%984.8M

64.35%217.1M

11.83%267.6M

123.45%259.2M

0.42%240.9M

52.86%727.3M

17.74%132.1M

47.08%239.3M

Operating gains losses

----

92.33%-7.1M

-785.71%-6.2M

----

Depreciation and amortization

44.96%18.7M

12.78%15M

3.70%53.2M

3.79%13.7M

3.10%13.3M

1.57%12.9M

6.40%13.3M

2.81%51.3M

4.76%13.2M

4.03%12.9M

Other non cash items

-41.03%-5.5M

-281.03%-10.5M

-109.33%-4.9M

-163.29%-5M

-118.00%-1.8M

-108.33%-3.9M

147.54%5.8M

-20.33%52.5M

-79.16%7.9M

-67.74%10M

Change In working capital

39.32%-108.8M

-68.71%39.8M

30.74%-97.8M

-4.44%-91.7M

730.14%46M

-57.28%-179.3M

87.33%127.2M

18.94%-141.2M

-165.26%-87.8M

84.23%-7.3M

-Change in receivables

111.95%16.5M

-132.95%-28.3M

-169.59%-58.5M

-279.65%-20.3M

124.01%14M

-4,832.14%-138.1M

205.69%85.9M

47.46%-21.7M

-19.86%11.3M

-48.35%-58.3M

-Change in inventory

-1,370.00%-14.7M

-272.00%-9.3M

-1.49%-13.6M

49.64%-7M

-416.67%-3.1M

78.26%-1M

-143.86%-2.5M

-78.67%-13.4M

-13,800.00%-13.9M

92.68%-600K

-Change in payables and accrued expense

-32.11%25.8M

-32.14%1.9M

28.31%57.1M

-353.85%-23.1M

76.68%39.4M

59.00%38M

125.93%2.8M

456.00%44.5M

126.38%9.1M

12.63%22.3M

-Change in other working capital

-74.42%-136.4M

84.15%75.5M

45.02%-82.8M

56.20%-41.3M

-114.68%-4.3M

40.08%-78.2M

-8.69%41M

-33.39%-150.6M

-648.41%-94.3M

257.53%29.3M

Cash from discontinued investing activities

Operating cash flow

118.44%232.2M

0.45%376.5M

21.87%978M

17.55%150.7M

33.87%346.2M

-16.30%106.3M

29.82%374.8M

34.15%802.5M

-26.58%128.2M

39.33%258.6M

Investing cash flow

Cash flow from continuing investing activities

64.79%-80M

432.56%735.3M

11.32%-719.6M

122.24%42.1M

-233.40%-313.4M

-34.44%-227.2M

38.45%-221.1M

-66.67%-811.5M

3.32%-189.3M

60.15%-94M

Net PPE purchase and sale

-0.89%-45.1M

7.51%-38.2M

-65.99%-230.4M

-99.24%-78.7M

4.51%-65.7M

-162.94%-44.7M

-205.93%-41.3M

-14.90%-138.8M

44.05%-39.5M

-195.28%-68.8M

Net business purchase and sale

----

---89.2M

-6,046.67%-89.2M

--0

----

--0

--1.5M

----

Net investment purchase and sale

80.98%-34M

532.59%777.8M

44.25%-377M

241.28%218.7M

-900.42%-237.1M

-17.63%-178.8M

47.99%-179.8M

-84.70%-676.2M

-23.64%-154.8M

89.25%-23.7M

Net other investing changes

---400K

---4.3M

-757.14%-23M

---8.7M

---10.6M

----

--3.5M

----

Cash from discontinued investing activities

Investing cash flow

64.79%-80M

432.56%735.3M

11.32%-719.6M

122.24%42.1M

-233.40%-313.4M

-34.44%-227.2M

38.45%-221.1M

-66.67%-811.5M

3.32%-189.3M

60.15%-94M

Financing cash flow

Cash flow from continuing financing activities

-294.33%-48M

-2,297.53%-1.07B

-115.78%-11.9M

-267.21%-92.8M

8.57%7.6M

3.35%24.7M

541.82%48.6M

68.30%75.4M

640.00%55.5M

-57.83%7M

Net issuance payments of debt

---100M

--0

Net common stock issuance

14.81%-11.5M

---1B

-21.05%-13.8M

---100K

33.33%-200K

---13.5M

--0

-5.56%-11.4M

--0

-50.00%-300K

Proceeds from stock option exercised by employees

110.93%52.1M

-28.86%46.1M

10.92%104.6M

-86.85%7.3M

6.85%7.8M

3.35%24.7M

752.63%64.8M

69.60%94.3M

620.78%55.5M

-56.55%7.3M

Net other financing activities

-15.56%11.4M

12.96%-14.1M

64.00%-2.7M

--0

--13.5M

-116.00%-16.2M

---7.5M

--0

Cash from discontinued financing activities

Financing cash flow

-294.33%-48M

-2,297.53%-1.07B

-115.78%-11.9M

-267.21%-92.8M

8.57%7.6M

3.35%24.7M

541.82%48.6M

68.30%75.4M

640.00%55.5M

-57.83%7M

Net cash flow

Beginning cash position

7.56%1.25B

25.65%1.21B

7.42%961.2M

14.57%1.11B

34.22%1.07B

43.06%1.16B

7.42%961.2M

21.13%894.8M

6.42%966.8M

-15.60%795.2M

Current changes in cash

208.32%104.2M

-78.35%43.8M

271.23%246.5M

1,885.71%100M

-76.46%40.4M

-431.49%-96.2M

348.22%202.3M

-57.46%66.4M

59.12%-5.6M

609.20%171.6M

End cash Position

27.02%1.36B

7.56%1.25B

25.65%1.21B

14.57%1.11B

34.22%1.07B

43.06%1.16B

7.42%961.2M

6.42%966.8M

Free cash flow

203.73%187.1M

1.44%338.3M

12.64%747.6M

-18.83%72M

47.79%280.5M

-44.00%61.6M

21.18%333.5M

39.02%663.7M

-14.71%88.7M

16.94%189.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	118.44%232.2M	0.45%376.5M	21.87%978M	17.55%150.7M	33.87%346.2M	-16.30%106.3M	29.82%374.8M	34.15%802.5M	-26.58%128.2M	39.33%258.6M
Net income from continuing operations	7.29%278.1M	27.27%306.6M	35.40%984.8M	64.35%217.1M	11.83%267.6M	123.45%259.2M	0.42%240.9M	52.86%727.3M	17.74%132.1M	47.08%239.3M
Operating gains losses	----	----	----	----	----	----	----	92.33%-7.1M	-785.71%-6.2M	----
Depreciation and amortization	44.96%18.7M	12.78%15M	3.70%53.2M	3.79%13.7M	3.10%13.3M	1.57%12.9M	6.40%13.3M	2.81%51.3M	4.76%13.2M	4.03%12.9M
Other non cash items	-41.03%-5.5M	-281.03%-10.5M	-109.33%-4.9M	-163.29%-5M	-118.00%-1.8M	-108.33%-3.9M	147.54%5.8M	-20.33%52.5M	-79.16%7.9M	-67.74%10M
Change In working capital	39.32%-108.8M	-68.71%39.8M	30.74%-97.8M	-4.44%-91.7M	730.14%46M	-57.28%-179.3M	87.33%127.2M	18.94%-141.2M	-165.26%-87.8M	84.23%-7.3M
-Change in receivables	111.95%16.5M	-132.95%-28.3M	-169.59%-58.5M	-279.65%-20.3M	124.01%14M	-4,832.14%-138.1M	205.69%85.9M	47.46%-21.7M	-19.86%11.3M	-48.35%-58.3M
-Change in inventory	-1,370.00%-14.7M	-272.00%-9.3M	-1.49%-13.6M	49.64%-7M	-416.67%-3.1M	78.26%-1M	-143.86%-2.5M	-78.67%-13.4M	-13,800.00%-13.9M	92.68%-600K
-Change in payables and accrued expense	-32.11%25.8M	-32.14%1.9M	28.31%57.1M	-353.85%-23.1M	76.68%39.4M	59.00%38M	125.93%2.8M	456.00%44.5M	126.38%9.1M	12.63%22.3M
-Change in other working capital	-74.42%-136.4M	84.15%75.5M	45.02%-82.8M	56.20%-41.3M	-114.68%-4.3M	40.08%-78.2M	-8.69%41M	-33.39%-150.6M	-648.41%-94.3M	257.53%29.3M
Cash from discontinued investing activities
Operating cash flow	118.44%232.2M	0.45%376.5M	21.87%978M	17.55%150.7M	33.87%346.2M	-16.30%106.3M	29.82%374.8M	34.15%802.5M	-26.58%128.2M	39.33%258.6M
Investing cash flow
Cash flow from continuing investing activities	64.79%-80M	432.56%735.3M	11.32%-719.6M	122.24%42.1M	-233.40%-313.4M	-34.44%-227.2M	38.45%-221.1M	-66.67%-811.5M	3.32%-189.3M	60.15%-94M
Net PPE purchase and sale	-0.89%-45.1M	7.51%-38.2M	-65.99%-230.4M	-99.24%-78.7M	4.51%-65.7M	-162.94%-44.7M	-205.93%-41.3M	-14.90%-138.8M	44.05%-39.5M	-195.28%-68.8M
Net business purchase and sale	----	----	---89.2M	-6,046.67%-89.2M	--0	----	----	--0	--1.5M	----
Net investment purchase and sale	80.98%-34M	532.59%777.8M	44.25%-377M	241.28%218.7M	-900.42%-237.1M	-17.63%-178.8M	47.99%-179.8M	-84.70%-676.2M	-23.64%-154.8M	89.25%-23.7M
Net other investing changes	---400K	---4.3M	-757.14%-23M	---8.7M	---10.6M	----	----	--3.5M	----	----
Cash from discontinued investing activities
Investing cash flow	64.79%-80M	432.56%735.3M	11.32%-719.6M	122.24%42.1M	-233.40%-313.4M	-34.44%-227.2M	38.45%-221.1M	-66.67%-811.5M	3.32%-189.3M	60.15%-94M
Financing cash flow
Cash flow from continuing financing activities	-294.33%-48M	-2,297.53%-1.07B	-115.78%-11.9M	-267.21%-92.8M	8.57%7.6M	3.35%24.7M	541.82%48.6M	68.30%75.4M	640.00%55.5M	-57.83%7M
Net issuance payments of debt	---100M	---100M	---100M	---100M	--0	--0	--0	--0	--0	--0
Net common stock issuance	14.81%-11.5M	---1B	-21.05%-13.8M	---100K	33.33%-200K	---13.5M	--0	-5.56%-11.4M	--0	-50.00%-300K
Proceeds from stock option exercised by employees	110.93%52.1M	-28.86%46.1M	10.92%104.6M	-86.85%7.3M	6.85%7.8M	3.35%24.7M	752.63%64.8M	69.60%94.3M	620.78%55.5M	-56.55%7.3M
Net other financing activities	-15.56%11.4M	12.96%-14.1M	64.00%-2.7M	--0	--0	--13.5M	-116.00%-16.2M	---7.5M	--0	--0
Cash from discontinued financing activities
Financing cash flow	-294.33%-48M	-2,297.53%-1.07B	-115.78%-11.9M	-267.21%-92.8M	8.57%7.6M	3.35%24.7M	541.82%48.6M	68.30%75.4M	640.00%55.5M	-57.83%7M
Net cash flow
Beginning cash position	7.56%1.25B	25.65%1.21B	7.42%961.2M	14.57%1.11B	34.22%1.07B	43.06%1.16B	7.42%961.2M	21.13%894.8M	6.42%966.8M	-15.60%795.2M
Current changes in cash	208.32%104.2M	-78.35%43.8M	271.23%246.5M	1,885.71%100M	-76.46%40.4M	-431.49%-96.2M	348.22%202.3M	-57.46%66.4M	59.12%-5.6M	609.20%171.6M
End cash Position	27.02%1.36B	7.56%1.25B	25.65%1.21B	25.65%1.21B	14.57%1.11B	34.22%1.07B	43.06%1.16B	7.42%961.2M	7.42%961.2M	6.42%966.8M
Free cash flow	203.73%187.1M	1.44%338.3M	12.64%747.6M	-18.83%72M	47.79%280.5M	-44.00%61.6M	21.18%333.5M	39.02%663.7M	-14.71%88.7M	16.94%189.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data